Scleroderma Clinical Trial Initiative Snags Sanofi as First Partner to Accelerate Research

Sanofi will be the inaugural partner for the Scleroderma Research Foundation’s new clinical trial initiative to advance treatments for the rare autoimmune disorder of the skin and organs.